Showing results (141-150 of 201) with videos related to
Sort By:
Pageof 21
Blood|June 21, 2024
Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescentsCaroline Diorio, Laura Hernandez-Miyares, Diego A Espinoza, et al.Blood|December 6, 2021
Impact of high-risk cytogenetics on outcomes for children and young adults receiving CD19-directed CAR T-cell therapyAllison Barz Leahy, Kaitlin J Devine, Yimei Li, et al.Pediatric Blood & Cancer|July 13, 2024
Healthcare utilization disparities among children with high-risk neuroblastoma treated on Children's Oncology Group clinical trialsJamie Shoag, Yimei Li, Kelly D Getz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2020
Successful Outcomes of Newly Diagnosed T Lymphoblastic Lymphoma: Results From Children's Oncology Group AALL0434Robert J Hayashi, Stuart S Winter, Kimberly P Dunsmore, et al.Cancer Cell|February 14, 2018
Ezh2 and Runx1 Mutations Collaborate to Initiate Lympho-Myeloid Leukemia in Early Thymic ProgenitorsChristopher A G Booth, Nikolaos Barkas, Wen Hao Neo, et al.The New England Journal of Medicine|October 16, 2014
Chimeric antigen receptor T cells for sustained remissions in leukemiaShannon L Maude, Noelle Frey, Pamela A Shaw, et al.Blood|January 5, 2023
Central nervous system status is prognostic in T-cell acute lymphoblastic leukemia: a Children's Oncology Group reportNathan P Gossai, Meenakshi Devidas, Zhiguo Chen, et al.Molecular Cancer Research : MCR|April 26, 2020
The NSD2 p.E1099K Mutation Is Enriched at Relapse and Confers Drug Resistance in a Cell Context-Dependent Manner in Pediatric Acute Lymphoblastic LeukemiaJoanna Pierro, Jason Saliba, Sonali Narang, et al.Blood|September 8, 2012
Targeting JAK1/2 and mTOR in murine xenograft models of Ph-like acute lymphoblastic leukemiaShannon L Maude, Sarah K Tasian, Tiffaney Vincent, et al.Medrxiv : the Preprint Server for Health Sciences|April 28, 2021
Proteomic Profiling of MIS-C Patients Reveals Heterogeneity Relating to Interferon Gamma Dysregulation and Vascular Endothelial DysfunctionCaroline Diorio, Rawan Shraim, Laura A Vella, et al.Pageof 21